Metformin vs Tofacitinib
Metformin vs Tofacitinib: Overview
This comparison examines the pharmacological differences between Metformin and Tofacitinib.
Mechanism of Action
Metformin: Activates AMP-activated protein kinase, decreasing hepatic glucose production.
Tofacitinib: Pan-JAK inhibitor with preference for JAK1 and JAK3 blocking pro-inflammatory cytokine signaling.
Pharmacokinetics
Half-life: Metformin — 4-9 hours; Tofacitinib — 3.2 hours.
Chemical Properties
Molecular Formula: Metformin — C4H11N5; Tofacitinib — C16H20N6O.
Molecular Weight: Metformin — 129.1640 g/mol; Tofacitinib — 312.3700 g/mol.
Type: Metformin — Small molecule; Tofacitinib — Small molecule.